尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Sazdanoff Catherine, 董事. Insider active across 1 company, notably Meridian Bioscience INC. In total, 2 reports have been recorded. History available since 26 January 2022. The latest transaction was filed on 26 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Catherine Sazdanoff is a Board Member at Meridian Bioscience Inc. She contributes to overseeing the company's activities and developing strategies for its growth. Her experience in the life sciences sector allows her to provide valuable insights to the board.